ADHD drug shows promise for brain tumor fatigue in kids

NCT ID NCT06905587

First seen Jan 11, 2026 · Last updated May 11, 2026 · Updated 19 times

Summary

This study tests whether methylphenidate, a drug used for ADHD, can reduce severe tiredness (fatigue) in people who had a brain tumor as a child or teen. About 50 survivors will receive either the drug or a placebo, then switch, to see if it improves energy and thinking. If effective, it could offer a new way to manage a common long-term side effect.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR, PEDIATRIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aalborg University Hospital

    NOT_YET_RECRUITING

    Aalborg, 9000, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Aarhus University Hospital

    RECRUITING

    Aarhus, 8200, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Odense University Hospital

    RECRUITING

    Odense, 5000, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Rigshospitalet

    NOT_YET_RECRUITING

    Copenhagen, 2100, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.